The judge presiding over all Abilify lawsuits hopes to settle issues of general causation about the link between Abilify and compulsive gambling by the end of this summer, paving the…
AstraZeneca has agreed to buy all of Bristol-Myers Squibb's diabetes drug interests, as a growing number of Byetta, Bydureon and Ongylza lawsuits continue to be filed by former users of…
More than 400 additional claims have been filed over Plavix safety and efficacy problems over the summer.
A new study suggests some cholesterol drugs could impair memory with regular use.
A number of Plavix users have developed a dangerous bleeding disorder, according to a warning letter sent out by the manufacturer.
Public Citizen is calling on the FDA to add a black box warning to Plavix about the risk of major bleeding events when used with drug-eluting stents.
The diabetes drug Onglyza proved to be no more effective than a placebo at preventing heart attacks and strokes in diabetics, according to data from a recent clinical trial.
AstraZeneca and Bristol-Myers Squibb will unveil new studies on diabetes drugs at an upcoming conference.
A conference in the Plavix litigation has been reset for next month, as complaints involving 1,000 plaintiffs were transferred into the MDL this week.
Following the centralization of all federal Plavix lawsuits earlier this year as part of an MDL or Multidistrict Litigation, an initial conference will be held early next week for the…
